References



·Anthony S. Fauci, M.D, 2010, Nation instute of ALlerfyt and Infectious Disease, [], Immune System · Marieb, E.N., Hoehn, K. (2007) Human Anatomy and Physiology, 7th edn, Benjamin Cummings New York.

· Blanco, P., Oaluckad, A., Pascuald, V. & Banchereaud, J. 2009, "Dendritic Cells and cytokines in human inflammatory and autoimmune dieseases", //PMC,// vol. 19, no. 1, pp. 41-52.


 * ·Bogaert, D. Weinberger, D. Thompson, C. Lipsitch, M. & Malley, R, 2009., Imparied Innate and Adaptive Immunity to//Streptococcus pneumonia// and its Effects on Colonization in an Infant Mouse Model, //American Society for Microbiology,// 77: 1613-1622.

 · ·Jaspan, H. Lawn, S. Safrit, J. & Bekker, L, 2006, The maturing immune system: implications of development and testing HIV-1 vaccines for children and adolescents, //AIDS,// 20: 483-494.

 · ·Liu, G. Zhang, L. & Zhao, Y, 2010, Modulation of immune responses through direct activation of Toll-like receptors to T cells,//The Journal of Translational Immunology,// 160: 168-175.

 · ·Netea, M. Van Der Graaf, C. Van Der Meer, J & Kullberg, B, 2004, Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system, //Journal of Leukoeyte Biology,// 75: 749-755.

 · ·Gallorini, S. Berti, F. Mancuso, G. Cozzi, R. Tortoli, M. Volpini, G. Telford, J. Beninati, C. Maione, D. & Wack, A, 2009, Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides,//PNAS,// 106: 17481-17486.

 · ·Jane, V. & Levy, O, 2009, Developmental Biology of the Innate Immune Response: Implication for Neonatal and Infant Vaccine Development, //The International Pediatric Research Foundation,// 65: 98-105.

 · ·Plotkin, S & Mortimer, E. 1988, //Vaccines//, 2nd edn, Philadelphia, United States.

 · ·Anderson, K.V., Bokla, L. & Nüsslein-Volhard, C. 1985, "Establishment of dorsal - ventral polarity in the drosophila embryo: The induction of polarity by the Toll Gene product", Cell, vol. 42, no. 3, pp. 791-798.

 · ·Flanagan, K.L., Burl, S. & Plebanski, M. 2010, "The Challenge of Assessing Infant Vaccine Responses in Resource poor Settings", Medscape Today, [Online], vol. 9, no. 6, pp. 2/9/2010. Available from: http://www.medscape.com/viewarticle/723928. [2/9/2010].

 · ·Levy, O., Suter, E.E., Miller, R.L. & Wessels, M.R. 2008, "Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells", Blood, vol. 108, no. 4, pp. 1284-1290.

 · ·Medzhitov, R., Hurlburt, P. & Janeway, C. 1997, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature, vol. 388, no. 1, pp. 394-397.  · ·Nerren, J.R., He, H., Genovese, K.J. & Kogut, M.H. 2009, "mRNA Expression of the Avian Specific Toll-Like Receptor 15 is induced by Multiple Species of Bacteria", The Journal of Immunology, vol. 182, no. 135, pp. 135-135.
 * Norman, B. 2010, //First evidence that the brain's native dendritic cells can muster an immune response//, The Rockefeller University

 · ·Rottinghaus, E., Vesosky, B. & Turner, J. 2010, "Elderly might not benefit from TB vaccines in development", Mechanisms of Ageing and Development, vol. 131, no. 6, pp. 605-614.

<span style="margin-bottom: 0cm; margin-left: 36pt; margin-right: 0cm; margin-top: 0cm; text-indent: -18pt;"> · ·Schnare, M., Barton, G.M., Holt, A.C., Takeda, S. & Medzhitov, R. 2001, "Toll-like receptors control activation of adaptive immune responses", Nature, vol. 2, no. 10, pp. 947-950.


 * Siegrist, C. 2008, "Section 1, General aspects of vaccination: Vaccine immunology" in Vaccines, 5th edn, Saunders,, pp. 17-35

<span style="margin-bottom: 0cm; margin-left: 36pt; margin-right: 0cm; margin-top: 0cm; text-indent: -18pt;"> · ·Shaw, A. 2008, "Vaccines Incorporating Toll-like Receptor Ligands", 2008, [Online], vol. 1, no. 1, pp. 1/9/2010. Available from: http://biopharminternational.findpharma.com/biopharm/article/articleDetail.jsp?id=557310&sk=&date=&&pageID=1. [1/9/2010].
 * <span style="font-family: Arial,Helvetica,sans-serif;">Steinman, M.,R. & Pope, M. 2002, "Exploiting dendritic cells to improve vaccine efficieny", The Journal of Clinical Investigation, vol. 109, no. 12, pp. 1519-26


 * <span style="font-family: Arial,Helvetica,sans-serif;">Turley, S. 2002, "Denditic cells: inciting and inhibiting autoimmunity", Current Opinion in Immunilogy, vol. 14, pp. 765-770.


 * <span style="font-family: Arial,Helvetica,sans-serif;">Upham, J., Rate, A., Rowe, J., Kusel, M., Sly, P. & Holt, P. 2006, "Dendritic Cell Immaturity during Infancy Restricts the Capacity To Express Vaccine-Specific T-Cell Memory", Infection and immunity, [Online], vol. 74, no. 2, pp. 1106-. [2005]


 * <span style="font-family: Arial,Helvetica,sans-serif;">Vogel, F. 2000, "Improving Vaccine Performance with Adjuvants", Clinical Infectious Diseases,, no. 30, pp. 266-270

<span style="margin-bottom: 0cm; margin-left: 36pt; margin-right: 0cm; margin-top: 0cm; text-indent: -18pt;"> · ·Antibody 2010, in //MedlinePlus encyclopaedia//, viewed 28 September 2010, MedlinePlus Online,<span style="background-attachment: initial; background-clip: initial; background-color: initial; background-origin: initial; background-position: 100% 50%; background-repeat: no-repeat no-repeat; color: blue; cursor: pointer;">[]

<span style="margin-bottom: 0cm; margin-left: 36pt; margin-right: 0cm; margin-top: 0cm; text-indent: -18pt;"> · ·Beaver, C, 2010, ‘ <span style="color: #212121; font-family: Arial,sans-serif;">Strategic immunogenicity testing’, //<span style="font-family: Arial,sans-serif;"> //, Vol. 19 Issue 6, p82-90. //


 * //<span style="color: black; font-family: 'Comic Sans MS'; font-size: 10pt; line-height: 115%; margin-left: 36pt; text-indent: -36pt;"> [|Perrie Y], [|Mohammed AR] , [|Kirby DJ] , [|McNeil SE] and [|Bramwell VW] , 2008, ‘Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens’, //International journal or pharmaceutics//, 8;364(2):272-80//


 * // Autoimmune disorder, 2010, in  //MedlinePlus encyclopaedia, //viewed 29 September 2010, MedlinePlus Online, []


 * Duthie, S.M, Kimber, I, and Norval, M, 1999, ‘The effects of ultraviolet radiation on the human immune system’, // British Journal of Dermatology //, 140: pp. 995–1009


 * Linder N, Abudi Y, Abdalla W, Badir M, Amitai Y, Samuels J, Mendelson E and Levy F, 2009, ‘Effect of Season of Inoculation on Immune Response to Rubella Vaccine in Children’ , // Journal of Tropical Pediatrics Advance Access  // . <span style="border-bottom-color: windowtext; border-bottom-style: none; border-bottom-width: 1pt; border-left-color: windowtext; border-left-style: none; border-left-width: 1pt; border-right-color: windowtext; border-right-style: none; border-right-width: 1pt; border-top-color: windowtext; border-top-style: none; border-top-width: 1pt; padding-bottom: 0cm; padding-left: 0cm; padding-right: 0cm; padding-top: 0cm;">doi:  10.1093/tropej/fmp104

> >
 * <span style="border-bottom-color: windowtext; border-bottom-style: none; border-bottom-width: 1pt; border-left-color: windowtext; border-left-style: none; border-left-width: 1pt; border-right-color: windowtext; border-right-style: none; border-right-width: 1pt; border-top-color: windowtext; border-top-style: none; border-top-width: 1pt; font-family: 'Comic Sans MS'; font-size: 10pt; line-height: 115%; padding-bottom: 0cm; padding-left: 0cm; padding-right: 0cm; padding-top: 0cm;">Peña-Cruz, V, McDonough, M.S, Diaz-Griffero, F,  <span style="border-bottom-color: windowtext; border-bottom-style: none; border-bottom-width: 1pt; border-left-color: windowtext; border-left-style: none; border-left-width: 1pt; border-right-color: windowtext; border-right-style: none; border-right-width: 1pt; border-top-color: windowtext; border-top-style: none; border-top-width: 1pt; padding-bottom: 0cm; padding-left: 0cm; padding-right: 0cm; padding-top: 0cm;">Crum, P.C, Carrasco, D.R, Freeman, J.G, 2010,  //<span style="border-bottom-color: windowtext; border-bottom-style: none; border-bottom-width: 1pt; border-left-color: windowtext; border-left-style: none; border-left-width: 1pt; border-right-color: windowtext; border-right-style: none; border-right-width: 1pt; border-top-color: windowtext; border-top-style: none; border-top-width: 1pt; font-family: 'Comic Sans MS'; font-style: normal; padding-bottom: 0cm; padding-left: 0cm; padding-right: 0cm; padding-top: 0cm;">Langerhans Cells // <span style="border-bottom-color: windowtext; border-bottom-style: none; border-bottom-width: 1pt; border-left-color: windowtext; border-left-style: none; border-left-width: 1pt; border-right-color: windowtext; border-right-style: none; border-right-width: 1pt; border-top-color: windowtext; border-top-style: none; border-top-width: 1pt; padding-bottom: 0cm; padding-left: 0cm; padding-right: 0cm; padding-top: 0cm;">Regulate Antigen-Presenting Cell Activity’, // <span style="border-bottom-color: windowtext; border-bottom-style: none; border-bottom-width: 1pt; border-left-color: windowtext; border-left-style: none; border-left-width: 1pt; border-right-color: windowtext; border-right-style: none; border-right-width: 1pt; border-top-color: windowtext; border-top-style: none; border-top-width: 1pt; padding-bottom: 0cm; padding-left: 0cm; padding-right: 0cm; padding-top: 0cm;">[[file:///C:/Users/44984/Documents/Sidz/2010/semester 2/com in Science/Essay/Essay V2.doc|Journal of Investigative Dermatology]], // Vol. 130 Issue 9, pp. 2222-2230